Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Pharmacy Linked to Meningitis Outbreak Cited for Filthy Conditions, Lack of Sterility

Filed October 24th, 2012 Laurie

The Massachusetts compounding pharmacy linked to an outbreak of fungal meningitis apparently failed to keep facilities clean, despite repeated requests to do so.

State officials said Tuesday that the New England Compounding Center (NECC) did not follow standard procedures to keep its facilities clean and its products sterile, according to The New York Times. In fact, NECC shipped some orders of the drug that spread the fungal meningitis before the final results of sterility testing came back. To date, 304 people have been sickened in the ongoing fungal meningitis outbreak that has impacted 17 states and led to 23 deaths.

NECC’s records indicate that the tests came back negative, but also suggested the center failed to sterilize the products for even the least amount of time it takes to ensure a clean product, said The New York Times. Dirty mats were seen just outside of the facility’s clean rooms, according to a report released Tuesday by the state’s Board of Registration in Pharmacy. Dirty hoods in the sterile compounding area and a leaking boiler next to a clean room were also observed, The New York Times noted.

Eric S. Kastango, president of Clinical IQ, a consulting firm that counsels compounding pharmacies, told The New York Times that he believes this catastrophe was entirely avoidable. “They failed to properly sterilize this medicine that had to be sterilized. That’s huge,” he said.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!